Dr. Cesar Angeletti is a pathologist practicing in New Haven, CT. Dr. Angeletti is a doctor who specializes in the study of bodily fluids and tissues. As a pathologist, Dr. Angeletti can help your primary care doctor make a diagnosis about your medical condition. Dr. Angeletti may perform a tissue biopsy to determine if a patient has cancer, practice genetic testing, and complete a number of laboratory examinations. Pathologists can also perform autopsies which can determine a persons cause of death and gain information about genetic progression of a disease.
Education and Training
Faculty Med Science Of La Plata 1990
- Modulation of neoangiogenesis in bronchial preneoplastic lesions.
- Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
- Postintubation tracheal tear repair by cervicotomy and longitudinal tracheotomy.
- Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study.
- Combined approach to intrathoracic lesions invading the spinal cord.
- Gastropleural fistula as complication of postpneumonectomy empyema.
- A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection.
- Surgical approaches to membranous tracheal wall lacerations.
- Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
- Gamma probe-guided thoracoscopic surgery of small pulmonary nodules.
- Mediastinal goitres: when the transthoracic approach?
- The multimodality treatment of thymic carcinoma.
- Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic
- Posterior wall laceration of the thoracic trachea: the transcervical-transtracheal approach.
- Acute major airway injuries: clinical features and management.
- Influence of bulla volume on postbullectomy outcome.
- Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
- Evolution of physiologic findings in a patient with bronchial adenoma treated by conservative bronchial surgery.
- Thymic carcinoma: a report of 13 cases.
- Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer.
- Videothoracoscopy for evaluation and treatment of hemothorax.
- A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma.
- [Leiomyoma of the lung (clinical case and review)].
- Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
- The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
- Relation of neovascularisation to metastasis of non-small-cell lung cancer.
- [REEXPANSION OF THE RESIDUAL PARENCHYMA AFTER PULMONARY EXERESIS: IMPORTANCE OF THE PNEUMOPERITONEUM].
- [THE SURGICAL TREATMENT OF ECHINOCOCCAL CYSTS OF THE LIVER. OBSERVATIONS ON 45 CASES].
- [CAUSES OF RESPIRATORY INSUFFICIENCY IN PULMONARY SURGERY].
- [CONSIDERATIONS ON THE TREATMENT OF CARCINOMA OF THE TRACHEA (CASE CONTRIBUTION)].
- [MALFORMATIVE BRONCHOPNEUMOPATHY].
- [EXPERIMENTAL STUDY ON THE VASCULARIZATION OF THE TRACHEA: TRANSPOSITION OF 2 SEMI-SEGMENTS OF WHICH ONE WAS VASCULARIZED].
- [EXPIRATORY TRACHEOBRONCHIAL COLLAPSE IN OBSTRUCTIVE CHRONIC PULMONARY EMPHYSEMA: THE SO-CALLED "HYPOTONIC TRACHEOBRONCHIAL DYSKINESIAS"].
- PRIMARY FIBROSARCOMA OF THE LUNG.
- [CLOSED INJURIES OF THE THORAX CAUSED BY TRAFFIC ACCIDENTS].
- Thymomas: clinical-pathological correlations.
- Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis.
- Long-term evaluation of intrapleural bacillus Calmette-Guerin with or without adjuvant chemotherapy in completely resected stages II and III non-small-cell lung cancer.
- Functional results of bronchial sleeve lobectomy.
- [The evaluation of the cardiotoxicity of 4'-epidoxorubicin at high doses].
- Results of treatment and lessons learned from pathologically staged T4 non-small cell lung cancer.
- Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy?
- Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer. Rationale for current approach.
- Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma.
- Ga-67 imaging of bronchial metastatic melanoma.
- Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers.
- Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer.
- Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer.
- Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients.
- Possible prognostic value of pulmonary AH-locus-linked enzymes in patients with tobacco-related lung cancer.
- Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients.
- Intrapleural BCG in postsurgical stage I non-small cell lung cancer.
- Influence of T and N stages on long-term survival in resectable small cell lung cancer.
- Optimal treatment for T1-3NOMO small cell lung cancer: surgery plus adjuvant chemotherapy.
- [Pulmonary metabolic activity in relation to carcinogenic substance exposure].
- Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
- A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay.
- [Mediastinoscopy and 67Ga scintigraphy in the clinical staging of pulmonary cancer].
- Penetration of clofoctol into human lung.
- [Results of the surgical resection of pulmonary cancer: actuarial analysis
- Surgical treatment of primary lung cancer and solitary brain metastasis.
- [Traumatic hernias of the diaphragm (considerations on 3 cases)].
- [Thoracic complications of hepatic echinococcosis].
- [Thoracic trachea carcinoma treated by circular resection followed by end to end anastomosis].
- [On primary carcinoma of the gastric stump after surgery of gastroduodenal ulcer].
- [Postoperative peptic ulcers. Review of cases].
- [Evolution in the treatment of fibrinolytic hemorrhage in prostatic surgery].
- Perfusion lung scan in the preoperative assessment of pulmonary function in bronchial carcinoma.
- Perfusion lung scan in the preoperative assessment of pulmonary function in bronchial carcinoma.
- Results of en bloc resections for lung cancer.
- Histone complements of human tissues, carcinomas, and carcinoma-derived cell
- [Association of secondary short esophagus and adenocarcinoma of the esophagogastric junction].
- [Nonmalignant tumors of the lung].
- Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
- mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations.
- Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer.
- [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
- Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype.
- Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.
- [The diagnosis of primary lesions of the anterior mediastinum].
- Inhibition of mouse parenchymal cells proliferation by mosquito larvae extract.
- Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
- p53 expression in non small cell lung cancer: clinical and biological correlations.
- Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
- p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.
- Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
- [Cardiac echinococcosis. Case report and review of the literature].
- Glutathione conjugation with 1-chloro-2,4-dinitrobenzene (CDNB): interindividual variability in human liver, lung, kidney and intestine.
- Energy metabolism of thoracic surgical patients in the early postoperative period. Effect of posture.
- p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation.
- [Pulmonary carcinoma and solitary intracranial metastasis: results of the combined surgical treatment].
- Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors.
- Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
- [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
- Second primary lung cancer and relapse: treatment and follow-up.
- Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
- Neoangiogenesis: a putative marker of malignancy in non-small-cell lung cancer (NSCLC) development.
- The utility of polyglactin-910 mesh in the plastic reconstruction of the chest wall after en-bloc resection.
- Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
- Late esophageal fistula complicating early postpneumonectomy empyema.
- [Mediastinal tumours. Analysis of 98 cases (author's transl)].
- Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
- Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
- Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
- Tumor angiogenesis and biologic markers in resected stage I NSCLC.
- Surgery in the management of small cell lung cancer.
- Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer.
- Treatment by VATS of giant bullous emphysema: results.
- Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
- [Current trends in in the treatment of spontaneous pneumothorax].
- Endothoracic sonography with color Doppler availability during video assisted thoracic surgery (videothoracoscopic operative staging with ultrasound color Doppler) for lung cancer staging.
- FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
- Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
- Adrenal masses in non-small cell lung carcinoma patients: is there any role for laparoscopic procedures?
- Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma.
- [Diagnosis and treatment of pleuro-pericardial cysts. Role of videosurgery].
- 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas.
- Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
- Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products.
- Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas.
- Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
- Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Dr. Cesar Augusto Angeletti MD's Practice location
New Haven, CT 06519Get Direction
AUSTELL, GA 30106Get Direction
Dr. Cesar Augusto Angeletti MD's reviewsWrite Review
- What to Expect After a Biopsy
Biopsies may vary differently depending on the type and location of the tissues and how hard are they to obtain. The medical term used to describe such method is “invasiveness.” A less invasive procedure will, for example, take place in a doctor’s office the same day an abnormal tissue is...
- How to Prepare for a Biopsy
A biopsy procedure is a very important procedure, which is used to identify the underlying cause of your abnormal body tissues. Depending on your condition and the location of the tissue abnormality, different types of biopsies may be performed on you. A biopsy preparation, therefore, depends on...
- Are There Vaccines Available For Cholera?
What Is Cholera?Cholera is an infectious disease that affects mostly the intestines, but causes complications to the rest of the body. Once a person suffers from cholera, the first parts of the body to be affected are the intestines. It is an infection caused by a bacteria known as the Vibrio...
- Treatments for Bladder Cancer
The treatment options or medications for bladder cancer depend largely on the advancement of cancer. The treatment is different for the early stage non-invasive bladder cancer and the more advanced muscle-invasive bladder cancer.During treatment, all hospitals have multidisciplinary teams (MDTs),...
- Is Shingles Contagious? How Do You Get Shingles?
Shingles is a contagious viral infection that is caused by the varicella zoster virus, the same virus that causes chickenpox. This virus affects a particular nerve section, causing painful rashes on the skin connected to that particular nerve. The rash normally appears in a form of a band on any...
- 5 Tips on Living with Mononucleosis
People with the mononucleosis (or mono) infection can live perfectly normal lives by doing what is best for them during their period of affliction. In this review, I have outlined the most essential tips on living with mononucleosis. In choosing these tips, the emphasis was focused on the well-being...
- Dr. Brett William Sramek DO21 Hartley Street New Haven CT 06520
- Dr. Stephanie Wain MD130 Division St Derby CT 06418
- Dr. Mary Lachman M.D.200 Watson Blvd Stratford CT 06615
- Dr. Neena Singh M.D.3 Sterling Dr Wallingford CT 06492
- Dr. Marguerite M Pinto MD267 Grant St Bridgeport CT 06610
- Dr. Jason Kang M.D.2160 S 1st Ave Maywood IL 60153